Goelzer Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Goelzer Investment Management's NVO Position: Q1 2017 in Review
Goelzer Investment Management sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 54,088 shares — an estimated $970K sold.
Goelzer Investment Management first reported a position in NVO in Q2 2013 and held it in 15 quarters. The position peaked at $5.08M in Q2 2013. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.
- Goelzer Investment Management reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
- Goelzer Investment Management sold 54,088 Novo Nordisk shares in Q1 2017, an estimated $970K.
- Goelzer Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 15 quarters.
- Goelzer Investment Management's Novo Nordisk position peaked at $5.08M in Q2 2013.
- 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.
Based on Goelzer Investment Management's 13F filing for Q1 2017, filed 5 May 2017.